Employer record · Cranberry Township, PA · FY2022–FY2026
EnlivenHealth, Inc.
USCIS approval rateFY24–26 · 6 approved
- Certified LCAs
- 9
- FY2024–FY2026
- USCIS approvals
- 6
- 2 new employment
- Denial rate
- 0.0%
- FY2024–FY2026
- Median wage offered
- $121k
- certified LCAs
Does EnlivenHealth, Inc. sponsor H-1B visas?
Yes — by its record, EnlivenHealth, Inc. is a small-scale H-1B sponsor: it filed 9 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 6 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided Jun 30, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.
Top sponsors in Texas →Medical devices and instruments sponsors →
Filings by fiscal year
Certified LCAs per U.S. government fiscal year (Oct–Sep) — 16 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.
| Fiscal year | certified LCAs | USCIS approvals | Approval rate |
|---|---|---|---|
| FY22 | 3 | 2 | 100% |
| FY23 | 4 | 4 | 100% |
| FY24 | 3 | 3 | 100% |
| FY25 | 3 | 0 | – |
| FY26 | 3 | 3 | 100% |
Occupations sponsored
| Occupation (SOC) | LCAs | Median wage |
|---|---|---|
| Software Developers 15-1252 | 5 | $150k |
| Software Quality Assurance Analysts and Testers 15-1253 | 3 | $126k |
| Statisticians 15-2041 | 1 | $104k |
Most-filed job titles
- Engineer II, Platform Engineering3$103k
- Engineer IV, Software2$143k
- Software Engineer III, Test2$128k
- Engineer III, Data Science1$104k
- Engineer IV, Software - Test1$121k
LCAs per title and median wage offered.
Where the jobs were
- Texas4 LCAs
- North Carolina4 LCAs
- Florida1 LCAs
We haven't indexed EnlivenHealth's jobs yet
We read jobs straight from employers' own career sites and haven't added EnlivenHealth's yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.
Also filed as
- ATEB INC (USCIS)
- EnlivenHealth, Inc. (LCA)
- Ateb, Inc. (LCA)
- ENLIVENHEALTH INC (USCIS)
EnlivenHealth, Inc. H-1B: questions people ask
Does EnlivenHealth, Inc. sponsor H-1B visas?
Yes — by its record, EnlivenHealth, Inc. is a small-scale H-1B sponsor: it filed 9 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 6 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided Jun 30, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.
Is EnlivenHealth, Inc. still sponsoring H-1B in 2026?
EnlivenHealth, Inc. had 3 certified LCAs in FY2026 (Oct 2025–Sep 2026), about the same as the 3 in FY2025. The latest one in our data was decided Jun 30, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.
How many H-1B petitions does EnlivenHealth, Inc. get approved?
USCIS recorded 6 approvals (2 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for EnlivenHealth, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).
What is the H-1B salary at EnlivenHealth, Inc.?
The median wage offered on EnlivenHealth, Inc.'s certified LCAs in FY2024–FY2026 was $121k a year. By job title: Engineer II, Platform Engineering $103k (3 LCAs), Engineer IV, Software $143k (2 LCAs) and Software Engineer III, Test $128k (2 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.
Which jobs does EnlivenHealth, Inc. sponsor for H-1B?
Its certified LCAs in FY2024–FY2026 were mostly for Software Developers (5), Software Quality Assurance Analysts and Testers (3) and Statisticians (1).
Where are EnlivenHealth, Inc.'s H-1B jobs?
By worksite on its certified LCAs (FY2024–FY2026): Texas (4), North Carolina (4) and Florida (1).
Is EnlivenHealth, Inc. an H-1B dependent employer?
No — its recent LCAs do not declare it H-1B dependent.
Does EnlivenHealth, Inc. have open jobs?
We read jobs straight from employers' own career sites and haven't added EnlivenHealth's yet.